Results 11 to 20 of about 2,195,632 (304)

The effect of 17β-estradiol on cutaneous wound healing in protein-malnourished ovariectomized female mouse model.

open access: yesPLoS ONE, 2014
Cutaneous wound healing is delayed by protein malnutrition (PM). On the other hand, estrogen promotes cutaneous wound healing by its anti-inflammatory and cell proliferation effects.
Kanae Mukai   +6 more
doaj   +3 more sources

Gellan Nanohydrogels: Novel Nanodelivery Systems for Cutaneous Administration of Piroxicam [PDF]

open access: yesMolecular Pharmaceutics, 2018
The feasibility to use gellan nanohydrogels (Ge-NHs) as delivery system for the cutaneous administration of piroxicam (PRX) was investigated using gellan conjugated with cholesterol or riboflavin. The in vitro skin penetration studies through human epidermis were performed using a saturated aqueous drug solution, a 50% w/v Transcutol aqueous solution ...
Musazzi, Umberto M.   +7 more
openaire   +5 more sources

Combined topical and systemic administration with human adipose-derived mesenchymal stem cells (hADSC) and hADSC-derived exosomes markedly promoted cutaneous wound healing and regeneration

open access: yesStem Cell Research & Therapy, 2021
Background Cutaneous wound healing and regeneration have become a recognized health challenge in the world, which causes severe damage to the mental and physical health of patients.
Yang Zhou   +11 more
doaj   +1 more source

Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management

open access: yesDermatology and Therapy, 2023
As an immune-response modifier, imiquimod can bind to Toll-like receptors on immune cells and enhance innate and adaptive immune responses, exerting potential antitumor and antiviral effects, which led to its approval by the US Food and Drug ...
Xiaoyan Zhang, Yao Xie, Lin Wang
doaj   +1 more source

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients

open access: yesFrontiers in Immunology, 2022
Pemphigus is an autoimmune mucocutaneous blistering disease caused by autoantibodies against desmogleins. Rituximab effectively treats pemphigus by inducing remission and rapidly reducing corticosteroid dosage.
Ahreum Song   +8 more
doaj   +1 more source

Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia. [PDF]

open access: yes, 2012
BACKGROUND: Cutaneous leishmaniasis is a vector-borne disease that is in Ethiopia mainly caused by the parasite Leishmania aethiopica. This neglected tropical disease is common in rural areas and causes serious morbidity.
Cloke, T   +70 more
core   +1 more source

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia

open access: yesTropical Medicine and Infectious Disease, 2022
The standard of care for cutaneous leishmaniasis includes the intramuscular/intravenous administration of pentavalent antimonials that are toxic and poorly tolerated.
Ernesto Rojas Cabrera   +9 more
doaj   +1 more source

Cutaneous Pseudolymphoma Following Administration of Lornoxicam

open access: yesActa Dermato-Venereologica, 2007
Since aspirin was introduced over a century ago, many new anti-inflammatory agents have been marketed. NSAIDs are currently the most commonly prescribed agents in Western medicine (1). Their widespread use has resulted in a number of well-documented adverse reactions. These most frequently involve the gastro-intestinal tract, causing discomfort, nausea
Stavrianeas, N.G.   +7 more
openaire   +3 more sources

Late cutaneous schistosomiasis representing an isolated skin manifestation of Schistosoma mansoni infection [PDF]

open access: yes, 2000
Ectopic late cutaneous schistosomiasis is usually preceded or accompanied by visceral schistosomiasis infection. Our patient presented the very rare case of late cutaneous schistosomiasis as an isolated skin manifestation.
Korting, Hans Christian   +5 more
core   +1 more source

Cutaneous Adverse Events in Newly Approved FDA Non-cancer Drugs: A Systematic Review

open access: yesDrugs in R&D, 2020
The prevalence of cutaneous adverse events attributable to newly approved anti-cancer drugs has been well reviewed in the dermatologic literature. In contrast, over 75% of US Food and Drug Administration approvals in the past 5 years have been for non ...
Paul C. Macklis   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy